Selected Recent Publications


1. Fritzmann J., Morkel M., Besser D., Budczies J., Kosel F., Brembeck F.H., Stein U., Fichtner I., Schlag P.M. and Birchmeier W. (2009). A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metas-tatic potential. Gastroenterology 137: 165-175.

2. Brembeck F.H., Rosario M., and Birchmeier W. (2006). Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 16:51-59.

3. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., Timm J., Mintzlaff S., Abraham C., Bock N., Kietzmann S., Goedde A., Toksoz E., Droege A., Krobitsch S., Korn B., Birchmeier W., Lehrach H., and Wanker E.E. (2005). A human protein-protein interaction network: a resource for annotating the proteome. Cell, 122:957-968.

4. Brembeck F.H., Schwarz-Romond, T., Bakkers, J., Wilhelm, S., Hammerschmidt, M., and Birchmeier, W. (2004). Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev. 18, 2225-2230.

5. Brembeck F.H., Schreiber F.S., Deramaudt T.B., Craig L., Rhoades B., Swain G., Grippo P., Stoffers D.A., Silberg,D.G., and Rustgi,A.K. (2003). The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 63, 2005-2009.